NYSE:HUMHealthcare
Humana (HUM) Valuation Check As Medicare Advantage Benefits And CGM Access Expand
Recent news around Humana (HUM) has centered on richer Medicare Advantage benefits, particularly broader access to continuous glucose monitors and expanded value based cardiac care. This provides investors with updated context for assessing the stock.
See our latest analysis for Humana.
The richer benefits arrive after a tough stretch for the stock, with a 30 day share price return of 10.14% and a 90 day share price return of 39.79% that leave the shares at US$165.43. A 1 year total...